NAV
₹3207.0371
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +3.65%
- 3Y
- +17.76%
- 5Y
- +15.42%
- Since Inception
- +18.15%
SIP returns (XIRR)
- 1Y
- +8.85%
- 3Y
- +11.25%
- 5Y
- +15.93%
- Since Inception
- +17.20%
Performance Comparison
Thinking about Franklin India Mid Cap FUND · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Fund HouseFranklin Templeton Mutual Fund
CategoryMid Cap
Launch Date01 Jan 2013
AMFI Code118533
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 30 Jun 2026
portfolio shared with Franklin India Mid Cap Fund-Growth
Holding% NAV
- 1Federal Bank Ltd2.73%
- 2Idfc First Bank Ltd2.35%
- 3Mahindra & Mahindra Financial Services Ltd2.13%
- 4Mankind Pharma Ltd2.10%
- 5Biocon Ltd2.08%
- 6Balkrishna Industries Ltd2.05%
- 7Prestige Estates Projects Ltd2.04%
- 8Tube Investments Of India Ltd2.03%
- 9Ipca Laboratories Ltd2.01%
- 10Mphasis Ltd2.00%
Rows per page· 75 total
Page 1/8
Investment Objective
Franklin India Mid Cap FUND · Direct · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, making them suitable for investors with moderate to high risk appetite.
About This Fund
Franklin India Mid Cap FUND · Direct · Growth is a Mid Cap mutual fund offered by Franklin Templeton Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations